SUP-425934 — Seed Brachytherapy Cesium 131 Ther D Gammatile 7 Pk 4 Seeds
Cite this view
HANK Price Transparency. (n.d.). SEED BRACHYTHERAPY CESIUM 131 THER D GAMMATILE 7 PK 4 SEEDS (CDM SUP-425934) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/SUP-425934?code_type=CDM
“SEED BRACHYTHERAPY CESIUM 131 THER D GAMMATILE 7 PK 4 SEEDS (CDM SUP-425934) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/SUP-425934?code_type=CDM. Accessed .
“SEED BRACHYTHERAPY CESIUM 131 THER D GAMMATILE 7 PK 4 SEEDS (CDM SUP-425934) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/SUP-425934?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $71,246–$96,027 (25th–75th percentile) across 1 hospital · 8 payers.
“Negotiated” is the hospital’s negotiated facility rate for this CDM SUP-425934 — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| LINDEN OAKS AT EDWARD Outpatient | Medicaid Replacement | — | $25,495.96 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Inpatient | Medicaid Replacement | — | $36,695.12 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Inpatient | Humana | Commercial | $50,753.64 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Inpatient | Ambetter | Commercial | $71,245.72 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Inpatient | Medicare Advantage | — | $71,245.72 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Inpatient | Cigna | Commercial | $74,105.08 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Inpatient | Blue Cross | Commercial | $77,202.72 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Outpatient | Cigna | Commercial | $78,155.84 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Inpatient | Aetna | Commercial | $81,968.32 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Inpatient | United Health Care | Commercial | $88,878.44 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Outpatient | Aetna | Commercial | $94,835.44 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Outpatient | Blue Cross | Commercial | $97,218.24 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Outpatient | United Health Care | Commercial | $124,143.88 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Outpatient | Medicare Advantage | — | $187,049.80 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |
| LINDEN OAKS AT EDWARD Outpatient | Ambetter | Commercial | $187,049.80 | $238,280.00 | $107,226.00 | 2026-08-01 | MRF ↗ |